552 related articles for article (PubMed ID: 8467360)
21. Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets.
Daniel JL; Dangelmaier C; Jin J; Ashby B; Smith JB; Kunapuli SP
J Biol Chem; 1998 Jan; 273(4):2024-9. PubMed ID: 9442039
[TBL] [Abstract][Full Text] [Related]
22. Antiplatelet action of R-99224, an active metabolite of a novel thienopyridine-type G(i)-linked P2T antagonist, CS-747.
Sugidachi A; Asai F; Yoneda K; Iwamura R; Ogawa T; Otsuguro K; Koike H
Br J Pharmacol; 2001 Jan; 132(1):47-54. PubMed ID: 11156560
[TBL] [Abstract][Full Text] [Related]
23. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.
Jin J; Daniel JL; Kunapuli SP
J Biol Chem; 1998 Jan; 273(4):2030-4. PubMed ID: 9442040
[TBL] [Abstract][Full Text] [Related]
24. FPL 66096: a novel, highly potent and selective antagonist at human platelet P2T-purinoceptors.
Humphries RG; Tomlinson W; Ingall AH; Cage PA; Leff P
Br J Pharmacol; 1994 Nov; 113(3):1057-63. PubMed ID: 7858849
[TBL] [Abstract][Full Text] [Related]
25. Aggregation of human and canine platelets: modulation by purine nucleotides.
Soslau G; Arabe L; Parker J; Pelleg A
Thromb Res; 1993 Oct; 72(2):127-37. PubMed ID: 8303650
[TBL] [Abstract][Full Text] [Related]
26. Contractile effects of uridine 5'-triphosphate in the rat duodenum.
Johnson CR; Hourani SM
Br J Pharmacol; 1994 Dec; 113(4):1191-6. PubMed ID: 7889272
[TBL] [Abstract][Full Text] [Related]
27. Occupancy of P2 purinoceptors with unique properties modulates the function of human platelets.
Soslau G; Brodsky I; Parker J
Biochim Biophys Acta; 1993 Jun; 1177(2):199-207. PubMed ID: 7684612
[TBL] [Abstract][Full Text] [Related]
28. Partial agonist behaviour of adenosine 5'-O-(2-thiodiphosphate) on human platelets.
Cusack NJ; Hourani SM
Br J Pharmacol; 1981 Jun; 73(2):405-8. PubMed ID: 7236992
[TBL] [Abstract][Full Text] [Related]
29. Activity of adenosine diphosphates and triphosphates on a P2Y(T) -type receptor in brain capillary endothelial cells.
Simon J; Vigne P; Eklund KM; Michel AD; Carruthers AM; Humphrey PP; Frelin C; Barnard EA
Br J Pharmacol; 2001 Jan; 132(1):173-82. PubMed ID: 11156575
[TBL] [Abstract][Full Text] [Related]
30. The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation.
Hechler B; Léon C; Vial C; Vigne P; Frelin C; Cazenave JP; Gachet C
Blood; 1998 Jul; 92(1):152-9. PubMed ID: 9639511
[TBL] [Abstract][Full Text] [Related]
31. Ap4A and ADP-beta-S binding to P2 purinoceptors present on rat brain synaptic terminals.
Pintor J; Díaz-Rey MA; Miras-Portugal MT
Br J Pharmacol; 1993 Apr; 108(4):1094-9. PubMed ID: 8485620
[TBL] [Abstract][Full Text] [Related]
32. Role of extracellular ATP metabolism in regulation of platelet reactivity.
Birk AV; Broekman MJ; Gladek EM; Robertson HD; Drosopoulos JH; Marcus AJ; Szeto HH
J Lab Clin Med; 2002 Sep; 140(3):166-75. PubMed ID: 12271274
[TBL] [Abstract][Full Text] [Related]
33. ATP derivatives are antagonists of the P2Y1 receptor: similarities to the platelet ADP receptor.
Hechler B; Vigne P; Léon C; Breittmayer JP; Gachet C; Frelin C
Mol Pharmacol; 1998 Apr; 53(4):727-33. PubMed ID: 9547364
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of ADP-induced platelet aggregation by adenosine tetraphosphate.
Harrison MJ; Brossmer R
Thromb Haemost; 1976 Nov; 36(2):388-91. PubMed ID: 1036839
[TBL] [Abstract][Full Text] [Related]
35. Separate P2T and P2U purinergic receptors with similar second messenger signaling pathways in UMR-106 osteoblasts.
Sistare FD; Rosenzweig BA; Contrera JG; Jordan B
J Pharmacol Exp Ther; 1994 Jun; 269(3):1049-61. PubMed ID: 8014849
[TBL] [Abstract][Full Text] [Related]
36. Interaction of human blood platelets with the 2',3'-dialdehyde and 2',3'-dialcohol derivatives of adenosine 5'-diphosphate and adenosine 5'-triphosphate.
Pearce PH; Wright JM; Egan CM; Scrutton MC
Eur J Biochem; 1978 Aug; 88(2):543-54. PubMed ID: 689037
[TBL] [Abstract][Full Text] [Related]
37. Platelet activation by 2-(4-bromo-2,3-dioxobutylthio)adenosine 5'-diphosphate is mediated by its binding to a putative ADP receptor, aggregin.
Puri RN; Colman RF; Colman RW
Eur J Biochem; 1996 Mar; 236(3):862-70. PubMed ID: 8665907
[TBL] [Abstract][Full Text] [Related]
38. Identification of a receptor for ADP on blood platelets by photoaffinity labelling.
Cristalli G; Mills DC
Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):875-81. PubMed ID: 8387782
[TBL] [Abstract][Full Text] [Related]
39. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.
Mills DC; Puri R; Hu CJ; Minniti C; Grana G; Freedman MD; Colman RF; Colman RW
Arterioscler Thromb; 1992 Apr; 12(4):430-6. PubMed ID: 1558834
[TBL] [Abstract][Full Text] [Related]
40. Secretory mechanisms. Behaviour of adenine nucleotides during the platelet release reaction induced by adenosine diphosphate and adrenaline.
Holmsen H; Day HJ; Setkowsky CA
Biochem J; 1972 Aug; 129(1):67-82. PubMed ID: 4675006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
